Skip to main content

Find Clinical Trials

Home
Conditions
Myositis

Clinical trial condition

Myositis

Explore clinical trials studying Myositis. Study availability and eligibility vary by location and protocol.

163 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Myositis trial results

Not yet recruiting

Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies

NCT07668505

Conditions: Muscular Diseases, Musculoskeletal Diseases, Myositis, +2 more
Locations: Prince of Wales Hospital Hong Kong

View Trial Details

Not yet recruiting

Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

NCT07552220

Conditions: Health Adult Subjects, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations: Centre Hospitalier de Mâcon Mâcon, France

View Trial Details

Not yet recruiting

YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases

NCT07439029

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +35 more
Locations: Children's Hospital of Fudan University Shanghai, China

View Trial Details

Not yet recruiting

TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)

NCT07355257

Conditions: Inflammatory Myopathy, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations: Not specified

View Trial Details

Not yet recruiting

Tongji NADs Cohort

NCT07333196

Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +40 more
Locations: Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not yet recruiting

GC012F in Patients With Autoimmune Diseases

NCT07072884

Conditions: Connective Tissue Diseases, Idiopathic Inflammatory Myopathy (IIM), Muscular Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

NCT06986018

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +14 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not yet recruiting

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

NCT06978738

Conditions: ANCA-associated Vasculitis, Anemia, Anemia, Hemolytic, +36 more
Locations: Changzhou No.2 People's Hospital Changzhou, China

View Trial Details

Not yet recruiting

Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT06970951

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +18 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not yet recruiting

Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature

NCT06740656

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brachial Plexus Neuritis, +22 more
Locations: CHRU Nancy Nancy, France

View Trial Details